Bratislava, Slovakia

Miroslav Palík

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Saneca Pharmaceuticals A.s.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miroslav Palík. Retrieved from https://idiyas.com/inventor/miroslav-palík

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Miroslav Palík: Innovator in Pharmaceutical Purification

Introduction

Miroslav Palík is a notable inventor based in Bratislava, Slovakia. He has made significant contributions to the field of pharmaceuticals, particularly in the purification of important compounds. His work has implications for the production of high-purity medications, which are essential for effective treatment.

Latest Patents

Miroslav Palík holds a patent for a method for isolation and purification of naltrexone. This invention describes a process for purifying naltrexone base from reaction mixtures that have been concentrated by evaporation. The method also addresses mixtures containing naltrexone alongside other organic or inorganic substances. By utilizing trituration, extraction, and crystallization from cyclopentyl methyl ether (CPME), this technique yields naltrexone of high purity, suitable for parenteral dosage forms.

Career Highlights

Miroslav Palík is currently employed at Saneca Pharmaceuticals a.s., where he applies his expertise in pharmaceutical development. His innovative approach to purification processes has positioned him as a valuable asset in the industry. His work not only enhances the quality of pharmaceutical products but also contributes to the overall efficiency of drug manufacturing.

Collaborations

Miroslav collaborates with several professionals in his field, including Miroslav Kavala and Dusan Vandák. These partnerships foster a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Miroslav Palík's contributions to the pharmaceutical industry through his patent for purifying naltrexone highlight his role as an innovator. His work at Saneca Pharmaceuticals a.s. and collaborations with fellow professionals further emphasize his commitment to advancing pharmaceutical sciences.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…